Intrinsic Value of S&P & Nasdaq Contact Us

Artiva Biotherapeutics, Inc. ARTV NASDAQ

NASDAQ Global Market • Healthcare • Biotechnology • US • USD

SharesGrow Score
65/100
3/6 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$20.50
+173.7%

Stock Statistics — ARTV

Artiva Biotherapeutics, Inc. (ARTV) has a market capitalization of $185.13M and trades at $7.49. The 52-week range is 1.47-7.754.

Key metrics include a trailing Price-to-Earnings (P/E) ratio of -2.2, Earnings Per Share (EPS) of $-3.43.

The stock has a beta of 2.19, operates in the Healthcare sector.

Trading Data
Current Price$7.49
52-Week Range1.47-7.754
Volume226.76K
Avg Volume (30D)174.96K
Market Cap$185.13M
Beta (1Y)2.19
Company
IPO Date2024-07-19
Employees96
CEOFred Aslan
CountryUS
ExchangeNASDAQ Global Market
CurrencyUSD
ISINUS04317A1079
Income (Latest Year)
Gross Profit$-2.6M
EBITDA$-88.01M
Operating Income$-90.61M
Net Income$-83.87M
EPS$-3.43
EPS Diluted$-3.43
Shares Outstanding$24.44M
Balance Sheet (Latest Year)
Total Assets$130.94M
Current Assets$112.67M
Cash & ST Investments$108.01M
Total Liabilities$20.97M
Total Debt$10.94M
Net Debt$-15.76M
Total Equity$109.97M
Debt / Equity0.10
Valuation Ratios
P/E Ratio-2.2
P/B Ratio1.68
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message